- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia ; volume:11 ; number:3 ; year:2018 ; pages:880-882
Case reports in oncology ; 11, Heft 3 (2018), 880-882
- Urheber
-
Pan, Elizabeth
Hsieh, Eric
Piatek, Caroline
- DOI
-
10.1159/000495032
- URN
-
urn:nbn:de:101:1-2019010923221764784399
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pan, Elizabeth
- Hsieh, Eric
- Piatek, Caroline
Ähnliche Objekte (12)
Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim
Erratum to: treatment of 5 dogs with immune-mediated thrombocytopenia using romiplostim
Immune-mediated neurological complications and dengue
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Immune-Mediated Coagulopathy in COVID-19 Infection
Immune monitoring and treatment in immune-mediated inflammatory diseases
Cancer risk in immune-mediated inflammatory diseases (IMID)
Guidelines for treatment of immune-mediated cerebellar ataxias
Immune-mediated entities of (primary) focal segmental glomerulosclerosis
Urine metabolome profiling of immune-mediated inflammatory diseases
Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions
Immune-mediated cerebellar ataxias: from bench to bedside
Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim
Erratum to: treatment of 5 dogs with immune-mediated thrombocytopenia using romiplostim
Immune-mediated neurological complications and dengue
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Immune-Mediated Coagulopathy in COVID-19 Infection
Immune monitoring and treatment in immune-mediated inflammatory diseases
Cancer risk in immune-mediated inflammatory diseases (IMID)
Guidelines for treatment of immune-mediated cerebellar ataxias
Immune-mediated entities of (primary) focal segmental glomerulosclerosis
Urine metabolome profiling of immune-mediated inflammatory diseases
Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions
Immune-mediated cerebellar ataxias: from bench to bedside
Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim
Erratum to: treatment of 5 dogs with immune-mediated thrombocytopenia using romiplostim
Immune-mediated neurological complications and dengue
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Immune-Mediated Coagulopathy in COVID-19 Infection
Immune monitoring and treatment in immune-mediated inflammatory diseases
Cancer risk in immune-mediated inflammatory diseases (IMID)
Guidelines for treatment of immune-mediated cerebellar ataxias
Immune-mediated entities of (primary) focal segmental glomerulosclerosis
Urine metabolome profiling of immune-mediated inflammatory diseases
Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions